The analyst, Michael Weinstein, said the device industry has now abandoned "its hard-line stance against increased taxation" but cautioned that the actual amount is "far from final."
Under a deal with White House and Senate negotiators, Mr. Weinstein said the industry is likely to end up paying 1.5-2 percent of $120 billion in U.S. sales revenue.
Read Bloomberg News’ report on the medical device tax.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
